Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/60176
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArintaya Phrommintikulen_US
dc.contributor.authorLavinia Tranen_US
dc.contributor.authorAndrew Kompaen_US
dc.contributor.authorBing Wangen_US
dc.contributor.authorAnastasia Adrahtasen_US
dc.contributor.authorDanielle Cantwellen_US
dc.contributor.authorDarren J. Kellyen_US
dc.contributor.authorHenry Krumen_US
dc.date.accessioned2018-09-10T03:39:00Z-
dc.date.available2018-09-10T03:39:00Z-
dc.date.issued2008-04-01en_US
dc.identifier.issn15221539en_US
dc.identifier.issn03636135en_US
dc.identifier.other2-s2.0-41749089597en_US
dc.identifier.other10.1152/ajpheart.01078.2007en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=41749089597&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/60176-
dc.description.abstractThe RhoA-Rho kinase (ROCK) signaling pathway has an important role in cardiovascular diseases. However, the effect of Rho kinase inhibition on pressure overload-induced cardiac hypertrophy (POH) and associated diastolic dysfunction has not been evaluated. This study examined the effect of a selective ROCK inhibitor (GSK-576371) in a POH model, induced by suprarenal abdominal aortic constriction. POH rats were divided into the following four groups: 1 (GSK 1, n = 9) or 3 (GSK 3, n = 10) mg/kg bid GSK-576371, 1 mg·kg-1·day-1ramipril (n = 10) or vehicle (n = 11) treatment for 4 wk. Sham animals (n = 11) underwent surgery without banding. Echocardiograms were performed before surgery and posttreatment, and hemodynamic data were obtained at completion of the study. Echocardiography showed an increase in relative wall thickness of the left ventricle (LV) following POH + vehicle treatment compared with sham animals. This was attenuated by both doses of GSK-576371 and ramipril. Vehicle treatment demonstrated abnormal diastolic parameters, including mitral valve (MV) inflow E wave deceleration time, isovolumic relaxation time, and MV annular velocity, which were dose dependently restored toward sham values by GSK-576371. LV end diastolic pressure was increased following POH + vehicle treatment compared with sham (6.9 ± 0.7 vs. 3.2 ± 0.7 mmHg, P = 0.008) and was reduced with GSK 3 and ramipril treatment (1.7 ± 0.7, P < 0.01 and 2.9 ± 0.6 mmHg, P < 0.01, respectively). Collagen I deposition in the LV was increased following POH + vehicle treatment (32.2%; P < 0.01) compared with sham animals and was significantly attenuated with GSK 1 (21.7%; P < 0.05), GSK 3 (23.8%; P < 0.01), and ramipril (35.5%; P 0.01) treatment. These results suggest that ROCK inhibition improves LV geometry and reduces collagen deposition accompanied by improved diastolic function in POH. Copyright © 2008 the American Physiological Society.en_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleEffects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunctionen_US
dc.typeJournalen_US
article.title.sourcetitleAmerican Journal of Physiology - Heart and Circulatory Physiologyen_US
article.volume294en_US
article.stream.affiliationsMonash Universityen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsUniversity of Melbourneen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.